Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-1995 | 10-1994 | 10-1993 | 10-1992 | 10-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 5,688 | 5,588 | 3,714 | 2,808 | 2,510 |
| TOTAL | $5,688 | $5,588 | $3,714 | $2,808 | $2,510 |
| Non-Current Assets | |||||
| PPE Net | 28,026 | 15,248 | 10,098 | 8,664 | 7,804 |
| Other Non-Current Assets | 3,901 | 4,143 | 4,417 | 4,459 | 4,796 |
| TOTAL | $31,927 | $19,391 | $14,515 | $13,123 | $12,600 |
| Total Assets | $37,615 | $24,979 | $18,229 | $15,931 | $15,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,813 | 11,564 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 12,724 | 7,731 | 8,117 | 3,570 | 3,527 |
| Accrued Expenses | 6,896 | 7,207 | 3,920 | 3,074 | 2,653 |
| TOTAL | $38,141 | $26,502 | $27,710 | $7,617 | $7,398 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 577 | 699 | 813 | 812 | 751 |
| TOTAL | $2,153 | $2,067 | $2,486 | $2,542 | $2,562 |
| Total Liabilities | $40,294 | $28,569 | $30,196 | $10,159 | $9,960 |
| Shareholders' Equity | |||||
| Common Shares | 55 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -6,562 | -7,108 | -7,608 | -132 | 447 |
| TOTAL | $6,611 | $16,620 | $16,100 | $16,546 | $20,125 |
| Total Liabilities And Equity | $46,905 | $45,189 | $46,296 | $26,705 | $30,085 |